title: Letter: cytokeratin-18 as a biomarker of hepatocellular carcinoma regression after transarterial chemoembolization.
authors.affiliation: Department of Hepatobiliary Surgery, Ruikang Hospital Affiliated to Guangxi University of Chinese Medicine, Nanning, China.
authors.forename: Z-H
authors.initials: ZH
authors.lastname: He
authors.affiliation: Department of Gastroenterology, People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, China.
authors.forename: W-R
authors.initials: WR
authors.lastname: He
authors.affiliation: School of Pharmacy, Guangxi Medical University, Nanning, China.
authors.forename: L-L
authors.initials: LL
authors.lastname: Wu
authors.affiliation: Department of Hepatobiliary surgery, Affiliated Tumor Hospital of Guangxi Medical University, Nanning, China.
authors.forename: C
authors.initials: C
authors.lastname: Zhao
authors.affiliation: Department of Hepatobiliary surgery, Affiliated Tumor Hospital of Guangxi Medical University, Nanning, China.
authors.forename: N-F
authors.initials: NF
authors.lastname: Peng
authors.affiliation: Section of Hematology and Oncology, Department of Medicine, University of Illinois at Chicago, Chicago, IL, USA.
authors.forename: B-K
authors.initials: BK
authors.lastname: Ahir
authors.affiliation: Department of Hepatobiliary Surgery, Ruikang Hospital Affiliated to Guangxi University of Chinese Medicine, Nanning, China.
authors.forename: C-Y
authors.initials: CY
authors.lastname: Lu
mesh_terms: D015415:Biomarkers; D006528:Carcinoma, Hepatocellular; D016461:Chemoembolization, Therapeutic; D006801:Humans; D053538:Keratin-18; D008113:Liver Neoplasms
chemical_list: D015415:Biomarkers; D053538:Keratin-18